Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Amplifica Completes $26 Million Series B Financing to Advance Injectable Pipeline for Hair Growth. The round, led by Tasso Partners, will support clinical development of innovative therapies aimed at hair loss.
PRIVATEAug 12, 2026•about 3 hours ago
Amount Raised
$26 Million
Round Type
Series B
Investors
Scopia Capital Management, LpEli Lilly And CompanyTasso Partners, Llc
Description
Amplifica Holdings Group, Inc. announced the closing of an oversubscribed $26 million Series B Preferred Stock financing. The round was led by Tasso Partners, with participation from Eli Lilly and other investors. Proceeds will be used to advance the clinical development of their novel pipeline candidates aimed at reactivating hair follicles
Don't miss Amplifica Holdings Group's next move
Get an email the moment Amplifica Holdings Group raises, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Funding Insights
Based on industry dataTimeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech